Frontiers in Genomics: 19 Years of In-Depth Science from National Experts
For nine years, IGS has welcomed scientific experts from around the world including Eric Green, Elodie Ghedin, Sarah Tishkoff, Atul Butte, Jay Shedure, Charles Rotimi, and Yasmine Belkaid...
Our belief is that we need to bring in worldwide experts to understand our knowledge and expand our science to make a difference in precision science and medicine.
Join us for our next Frontiers in Genomics:
Oct. 15, 2026
3 pm Taylor Hall in The Bressler Research Building, 655 W. Baltimore Street
4 pm Reception & Poster Presentation, HSFIII Atrium, 670 W. Baltimore Street
Philip L. De Jager, MD, PhD
Professor of Neurology
Columbia University
Dissecting the Signaling Networks of Cellular Communities Driving Trajectories of Alzheimer’s Disease & Brain Aging
Philip De Jager, MD PhD, Columbia University [De Jager Lab] is the Weil-Granat Professor of Neurology at Columbia University Medical Center, where he is the Chief of the Division of Neuroimmunology and directs the Multiple Sclerosis Center and the Center for Translational & Computational Neuroimmunology. He is also the Deputy Director of the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain. He graduated from Yale University (Molecular Biophysics & Biochemistry and Medieval French literature) and from the MD PhD program at Rockefeller University and Cornell University Medical College. He completed his neurology residency at Massachusetts General Hospital and Brigham and Women’s Hospital, and he completed his specialization in Clinical Neuroimmunology at the Brigham and Women’s Hospital.
Dr. De Jager’s research program couples modern methods of human immunology and genomics with advanced computational modeling methods to understand how immune responses drive different trajectories of aging and neurodegenerative diseases in the human brain. Focusing on Alzheimer’s Disease and Multiple Sclerosis, he leverages these insights to identify novel therapeutic targets and clinically deploy novel interventions with which to modulate immune responses and guide the human brain towards successful brain aging.